GlassScriptPhysician profile
John M Kelso
NPI 1720066970
$4,849.11
in general payments reported to CMS, 2019-2025
20 companies · $912 in 2025
The $912 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2020: $54.10 · 2021: $834 · 2022: $937 · 2023: $735 · 2024: $389 · 2025: $912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,036.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,066.62 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $715.35 | 2020-2025 | Tezspire, Fasenra, Breztri |
| Genzyme Corporation | $627.74 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $584.89 | 2019-2023 | |
| Csl Behring | $337.56 | 2019-2025 | Hizentra, Andembry |
| Pfizer INC. | $241.60 | 2019-2022 | |
| Leo Pharma INC. | $219.39 | 2023-2025 | Adbry |
| Grifols USA, LLC | $213.04 | 2021-2022 | |
| Shire North American Group INC | $173.19 | 2019 | |
| Kyowa Kirin, INC. | $120.00 | 2025 | |
| Optinose US, INC. | $113.85 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $113.61 | 2019 | |
| Biocryst US Sales Co., LLC | $109.55 | 2021 | |
| Abbvie INC. | $100.64 | 2022 | |
| Kaleo, INC. | $26.81 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $23.21 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.09 | 2019 | |
| Amgen INC. | $15.95 | 2025 | Tezspire |
| Genentech USA, INC. | $14.34 | 2019 | |
| Pharming Healthcare, INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kelso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.